EUVIMEDEUVIMED entdecken
Crossref

Kidney Transplant Outcomes in Patients with Atypical Hemolytic Uremic Syndrome

Manish R Balwani, Amit S Pasari, Prasad Gurjar, Amol Bhawane, Charulata Bawankule, Priyanka Tolani, Pranjal Kashiv, Shubham Dubey, Vijay M Katekhaye

Transplantation Proceedings · 2023

DOI: 10.1016/j.transproceed.2023.02.066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Manish R Balwani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Saraswati Kidney Care Center, Nagpur, Maharashtra, India; Department of Nephrology, Jawaharlal Nehru Medical College, Sawan…. Hauptthemen laut MEDLINE: Atypical Hemolytic Uremic Syndrome, Kidney Transplantation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Atypical hemolytic uremic syndrome (aHUS) is a rare disorder with a high probability of recurrence after a kidney transplant and can adversely affect the graft outcome. Our objective was to assess the transplant outcome of patients with aHUS who had undergone a kidney transplant. METHODS: We retrospectively included patients who had undergone a kidney transplant and been diagnosed with aHUS based on an anti-complement factor H (AFH) antibody level >100 AU/mL and the presence of a genetic abnormality in complement factor H (CHF) or CHF-related (CFHR) genes. Data were analyzed with descriptive statistics. RESULTS: Among 47 patients with AFH antibody levels >100 AU/mL, 5 (10.6%) had undergone a kidney transplant. The mean age was 24.2 years, and all were male. Atypical hemolytic uremic syndrome was diagnosed before transplant in 4 (80.0%) cases, whereas 1 was diagnosed after transplant owing to disease recurrence in the transplanted graft. Genetic analysis of all cases revealed one or more abnormalities in CFH and CFHR genes 1 and 3. With an average of 5 sessions of plasma exchange and the use of rituximab in 4 cases, there was a reduction in the disease severity with no recurrences in the post-transplant period. At the latest follow-up of 223 days, the mean serum creatinine level was 1.89 mg/dL, indicating good graft function. CONCLUSIONS: Among patients diagnosed with aHUS, the use of pre-transplant plasma exchange and rituximab can be beneficial in terms of preventing graft dysfunction and reducing disease recurrence in the post-transplant period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atypical Hemolytic Uremic SyndromeKidney TransplantationHumansMaleYoung AdultAdultFemaleComplement Factor HRituximabRetrospective StudiesMutation

Substanzen

Complement Factor HRituximab

Autor:innen und Institutionen

  • Department of Nephrology, Saraswati Kidney Care Center, Nagpur, Maharashtra, India; Department of Nephrology, Jawaharlal Nehru Medical College, Sawangi, Wardha, Maharashtra, India. Electronic address: balwani.manish@yah…
  • Department of Nephrology, Saraswati Kidney Care Center, Nagpur, Maharashtra, India; Department of Nephrology, Jawaharlal Nehru Medical College, Sawangi, Wardha, Maharashtra, India.
  • Department of Nephrology, Jawaharlal Nehru Medical College, Sawangi, Wardha, Maharashtra, India.
  • Department of Nephrology, AIIMS, Nagpur, Maharashtra, India.
  • Department of Nephrology, Saraswati Kidney Care Center, Nagpur, Maharashtra, India.
  • Department of Internal Medicine, Jawaharlal Nehru Medical College, Sawangi, Wardha, Maharashtra, India.

Zitieren

APA

Balwani, M. R., Pasari, A. S., Gurjar, P., Bhawane, A., Bawankule, C., Tolani, P., Kashiv, P., Dubey, S., & Katekhaye, V. M. (2023). Kidney Transplant Outcomes in Patients with Atypical Hemolytic Uremic Syndrome. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2023.02.066

Vancouver

Balwani MR, Pasari AS, Gurjar P, Bhawane A, Bawankule C, Tolani P, et al. Kidney Transplant Outcomes in Patients with Atypical Hemolytic Uremic Syndrome. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2023.02.066

BibTeX
@article{Balwani2023,
  author = {Balwani, Manish R and Pasari, Amit S and Gurjar, Prasad and Bhawane, Amol and Bawankule, Charulata and Tolani, Priyanka and Kashiv, Pranjal and Dubey, Shubham and Katekhaye, Vijay M},
  title = {Kidney Transplant Outcomes in Patients with Atypical Hemolytic Uremic Syndrome},
  journal = {Transplantation Proceedings},
  year = {2023},
  doi = {10.1016/j.transproceed.2023.02.066}
}
Kostenlos starten →